Market Close Commentary; 17 June 2020 

  • Jun 17, 2020 AEST
  • Team Kalkine

Despite fluctuating a bit during the trading session, the benchmark index S&P/ASX200 managed to finish in the green zone. It ended at 5991.8, up by 0.83 per cent as compared to Tuesday's closure of 5942.3. Moreover, all sectors finished in the green zone except the Materials.

The market gain has added to yesterday's substantial increase of 3.89 per cent. The market is reflecting positive sentiments after Dallas Federal Reserve President Robert Kaplan comment on Monday that the US economy would see a notable historic contraction in the second quarter but will begin to rebound after that. He also emphasised that if consumers and enterprises both will take extra precautions to stop the virus infection from spreading the economic recovery will even be quicker.

The best-performing stocks for today's market are:

  • CLINUVEL Pharmaceuticals Limited (ASX:CUV),up by 8.08 per cent and traded at AUD 27.020, and
  • a2 Milk Company Limited (ASX:A2M) which was up by 7.788 per cent and traded at AUD 19.100.

The worst-performing stocks for today's market are:

  • Pilbara Minerals Limited (ASX: PLS) which traded at AUD 0.265, down by 5.357 per cent and
  • Mayne Pharma Group Limited (ASX:MYX)which traded at AUD 0.365, down by 5.195 per cent.

Let's see the graph below to view the top five best and worst-performing stocks today:


The website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. All pictures are copyright to their respective owner(s). does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no one left untouched by the charm of the multibillion-dollar global boom in cannabis. Its glorious journey from a criminalized drug to being used in over 20 countries for treating medical conditions.

No wonder the cannabis stocks are on the edge of a green rush. Don’t miss out on the happenings in the cannabis sector and take advantage of the growth phase of this sector by subscribing to our report on Marijuana stocks in Australia.

Find out the drivers for the rise in cannabis stock rates Even though the cannabis sector is in its growing phase, Australian cannabis stocks have already started to rise actively due to a hastily increasing patient base, and a legislative landscape that is gradually beginning to liberalise.

Outreach and future of cannabis stocks As countries liberalise regulation for medical and recreational use of cannabis, it is predicted that the industry would grow sharply in upcoming years The global cannabis market stands currently at around $8 billion and it is expected that the hemp derived CBD market to hit approximately $22 billion by 2022. 

Key Players in the sector Althea Group Holdings Limited (ASX: AGH) and Cann Group Limited (ASX: CAN) are amongst the top players. Other Australia cannabis market players are- MGC Pharmaceuticals Ltd (ASX: MXC), Elixinol Global Limited (ASX: EXL), THC Global Group Limited (ASX: THC), AusCann Group Holdings Limited (ASX: AC8)

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK